血清T_3、T_4联合测定对非甲状腺疾病诊断的意义

• 作 者: 胡宏根
• 机 构: 广东省鹤山市人民医院放免室
• 出 处: 同位素
• 发表日期: 1996年S1期
• 关键词: 非甲状腺疾病 T_3 T_4 联合测定 肝硬化组 慢性肝炎 胆道疾病 重症组 临界值 肝细胞变性

对照组取ｘ±２ｓ为其上、下临界值．与对照组比较．甲亢、甲减组Ｔ３、Ｔ４均有显著差异（Ｐ＜０．００１）；轻、重肝硬化组Ｔ３均有显著差异（Ｐ＜０．００１）．轻症组Ｔ４无明显差异（Ｐ＞０．０５）．重症组Ｔ４有明显差异（Ｐ＜０．０１）；急、慢性肝炎组Ｔ３、Ｔ４均无显著差异（Ｐ＞０．０５），重症肝炎组Ｔ３有显著差异（Ｐ＜０．００１），Ｔ４无明显差异（Ｐ＞０．０５）；胆道疾病组Ｔ３有显著差异（Ｐ＜０．０１），Ｔ４差异不明显。血清Ｔ３、Ｔ４联合测定对非甲状腺疾病的诊断、病情分析及预后有一定价值。

The control group took x ± 2s as its upper and lower critical value. Compared with the control group. Hyperthyroidism, hypothyroidism T3, T4 were significantly different (P <0.001); light and severe cirrhosis group T3 were significantly different (P <0.001). There was no significant difference in mild group T4 (P> 0.05). (P <0.01); there was no significant difference in T3 and T4 between acute and chronic hepatitis groups (P> 0.05), T3 in severe hepatitis group was significantly different (P <0.001), T4 No significant difference (P> 0.05); biliary disease group T3 was significantly different (P <0.01), T4 difference was not significant. Serum T3, T4 combined determination of non-thyroid disease diagnosis, disease analysis and prognosis of a certain value.